GINKGO BIOWORKS HOLDINGS, INC. Marketable Securities
GINKGO BIOWORKS HOLDINGS, INC. (DNA) had Marketable Securities of $217.63 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2026-08-06
- 2026-06-30: Marketable Securities $217.63M.
- 2026-03-31: Marketable Securities $229.59M.
- 2025-12-31: Marketable Securities $255.42M.
- 2025-09-30: Marketable Securities $350.80M.
| Period end | Marketable Securities |
|---|---|
| 2026-06-30 | $217.63M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $229.59M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $255.42M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $350.80M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $270.13M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $204.50M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $0.00 10-Q · filed 2025-11-06 |